Markets:

Overview

News

Currencies

International

Treasuries

Poseida Therapeutics, Inc. - Common Stock (NQ:PSTX)

9.500 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 7, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Poseida Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q4 2023 ↗

March 07, 2024

PSTX stock results show that Poseida Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial ↗

December 11, 2023

Poseida Therapeutics Inc (NASDAQ: PSTX) released early efficacy and safety results from its Phase 1 study of P-BCMA-ALLO1, its BCMA-targeted allogeneic, T stem cell memory (TSCM)-rich chimeric antigen...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 11, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

December 11, 2023

It's time to start the trading week with a look at the biggest pre-market stock movers worth watching for Monday morning!

Via InvestorPlace

Poseida Therapeutics: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Looking Into Poseida Therapeutics's Return On Capital Employed ↗

March 15, 2023

Via Benzinga

Poseida Therapeutics Ushers New Era For Gene Therapies, Analyst Initiating Coverage Says ↗

January 04, 2023

Via Benzinga

Poseida Therapeutics Earnings Perspective: Return On Invested Capital ↗

December 22, 2022

Via Benzinga

Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare ↗

November 17, 2023

Are you looking for biotech breakthrough stocks? Here are three revolutionary stocks redefining healthcare.

Via InvestorPlace

Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich ↗

October 03, 2023

Are you looking to invest in biotechnology breakthroughs? Here are three biotech stocks that could make early investors rich.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 22, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 07, 2023

Via Benzinga

Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session ↗

August 09, 2023

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.

Via Benzinga

Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 07, 2023

Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...

Via Benzinga

Why Are Poseida Therapeutics Shares Moving Higher Today? ↗

August 07, 2023

Poseida Therapeutics Inc (NASDAQ: PSTX) shares are trading higher after the company received a $50 million strategic investment by Astellas Pharma Inc (OTC: ALMPY) (OTC:

Via Benzinga

PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories ↗

August 07, 2023

Benzinga

Via Benzinga

Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 10, 2023

Gainers Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 31, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 23, 2023

Via Benzinga

Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 04, 2023

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...

Via Benzinga

Alibaba, XPeng, Dada Nexus And Some Other Big Stocks Moving Higher On Wednesday ↗

January 04, 2023

U.S. stocks traded mixed, with the Dow Jones dropping around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023 ↗

January 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 17, 2022

Gainers Cyclerion Therapeutics (NASDAQ:CYCN) shares increased by 10.8% to $0.39 during Monday's after-market session. The market value of their outstanding shares is at $16.8 million.

Via Benzinga

$7.5 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

August 11, 2022

The Dow Jones jumped by more than 500 points on Wednesday following inflation data for July. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Piper Sandler Maintains Overweight Rating for Poseida Therapeutics: Here's What You Need To Know ↗

August 09, 2022

Piper Sandler has decided to maintain its Overweight rating of Poseida Therapeutics (NASDAQ:PSTX) and raise its price target from $9.00 to $11.00. Shares of Poseida Therapeutics are trading up 1.08%...

Via Benzinga

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate ↗

August 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session ↗

August 04, 2022

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 04, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 04, 2022

Good morning! It's time for another dive into the biggest pre-market stock movers as we see what's affecting shares on Thursday!

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.